- Near-infrared photoimmunotherapy of pancreatic cancer using an indocyanine green-labeled anti-tissue factor antibody
Winn Aung et al, 2018, World Journal of Gastroenterology CrossRef - Influence of the dissociation rate constant on the intra-tumor distribution of antibody-drug conjugate against tissue factor
Ryo Tsumura et al, 2018, Journal of Controlled Release CrossRef - Nanobody Conjugates for Targeted Cancer Therapy and Imaging
Wei Kang et al, 2021, Technology in Cancer Research & Treatment CrossRef - Inhibition of the Classical Pathway of Complement Activation Impairs Bacterial Clearance during Enterococcus faecalis Infection
Eman M. Rabie Shehab El-Din et al, 2021, Infection and Immunity CrossRef - Molecular imaging using an anti-human tissue factor monoclonal antibody in an orthotopic glioma xenograft model
Hiroki Takashima et al, 2017, Scientific Reports CrossRef - Pharmacokinetics of protein and peptide conjugates
Brandon Bumbaca et al, 2019, Drug Metabolism and Pharmacokinetics CrossRef - Preclinical Studies of ADC Therapy for Solid Tumors
Yoshikatsu Koga et al, 2019, Cancer Drug Delivery Systems Based on the Tumor Microenvironment CrossRef - Preclinical studies of immunomicelles incorporating anticancer drugs
Hiroki Takashima et al, 2019, Drug Delivery System CrossRef - Evaluation of the antitumor mechanism of antibody‐drug conjugates against tissue factor in stroma‐rich allograft models
Ryo Tsumura et al, 2019, Cancer Science CrossRef - Modification of nitric oxide donors onto a monoclonal antibody boosts accumulation in solid tumors
Takuma Yoshikawa et al, 2020, International Journal of Pharmaceutics CrossRef - Reinforcement of antitumor effect of micelles containing anticancer drugs by binding of an anti-tissue factor antibody without direct cytocidal effects
Hiroki Takashima et al, 2020, Journal of Controlled Release CrossRef - Covalently Engineered Nanobody Chimeras for Targeted Membrane Protein Degradation
Heng Zhang et al, 2021, Journal of the American Chemical Society CrossRef - Tissue factor (coagulation factor III): a potential double-edge molecule to be targeted and re-targeted toward cancer
Seyed Esmaeil Ahmadi et al, 2023, Biomarker Research CrossRef - Radioimmunotherapy with an 211At‐labeled anti–tissue factor antibody protected by sodium ascorbate
Hiroki Takashima et al, 2021, Cancer Science CrossRef - The natural sulfoglycolipid derivative SQAP improves the therapeutic efficacy of tissue factor-targeted radioimmunotherapy in the stroma-rich pancreatic cancer model BxPC-3
Yoichi Takakusagi et al, 2022, Translational Oncology CrossRef - Functional Characteristics and Regulated Expression of Alternatively Spliced Tissue Factor: An Update
Kateryna Matiash et al, 2021, Cancers CrossRef